2008

NOVA receives CE mark
First installations in Europe
First Installation in Canada
VERiTAS trial begins enrolling patients

2007

Health Canada Medical Device License
Renal and Lower Extremity applications

2006

The first International Symposium on Flow Measurement in Cerebrovascular Surgery

VasSol, Inc. co-founder and President, Fady T. Charbel is a recipient of the Wall Street Journal’s 2006 Technology Innovation Awards

2005

A flow based algorithm for the management of symptomatic vertebrobasilar disease is published in the AHA journal, Stroke.*

*Amin-Hanjani S, Du X, Zhao M, Walsh K, Malisch TW, Charbel FT. Use of quantitative magnetic resonance angiography to stratify stroke risk in symptomatic vertebrobasilar disease. Stroke. Jun 2005;36(6):1140-1145.

2004

NOVA installed at major teaching hospitals in New York and Texas; agreements pending at five additional institutions.

NOVA's capability highlighted in NBC5 story on "Strokes Strike Young and Old" airing January 21, 2004.

VasSol participates in The 7th Annual Joint Meeting of the American Association of Neurological Surgeons and Congress of Neurological Surgeons.

2003

Neurovascular application available for widespread use;
delivered and installed at four major teaching hospitals.

Product name changed from CANVAS to NOVA (Non-invasive Optimal Vessel Analysis) to better reflect its broad-based application to the vascular system.

2002

FDA 510k premarket certification compliance awarded.

First study of core technology conducted on the liver.
VasSol moves into new Chicago headquarters as company growth continues.

2001

VasSol signs exclusive worldwide license for CANVAS technology with the University of Illinois at Chicago (UIC) Medical.

Founder and President, Fady T. Charbel M.D. names management specialist Anthony P. Curcio as VasSol, Inc. CEO.

Corporate name changes from Vascular Solutions to VasSol, Inc.

Corporate headquarters established at the Chicago Technology Park.

Meide Zhao, professor of computer science at the University of Illinois Department of Neurosurgery joins VasSol as Chief Technology Officer.

M.E. Clark, Professor of Theoretical and Applied Mechanics at the University of Illinois Urbana-Champaign (UIUC) is appointed Chief Engineering Advisor.

First round of Angel funding completed.

2000

Simulation and patient studies continue.

1999

Fady T. Charbel M.D., Director of Neurovascular research at UIC Medical, incorporates Vascular Solutions.

1998

Successfully conducts study using treatment planning component of core technology.

1997

Successfully conducts first blood flow study on human patient using diagnostic component of core technology.

First model of core technology, CANVAS, Computer Aided Neurovascular Analysis and Simulation, applied to neurovascular environment.

1996

Professor Meide Zhao joins original Neurovascular team to expand research of computer model for blood flow simulation.

1995-1992

Begin testing model concept for application on human subjects.

1991

Fady T. Charbel M.D. Dept. of neurosurgery, teams with Professor M.E. Clark (the originator of the concept to apply fluid mechanics to the analysis of blood flow) to model the network of blood vessels in the brain.

1990

Detroit, Michigan neurosurgeon Fady T. Charbel identifies the need to non-invasively analyze the severity of vascular disease and accurately predict treatment outcome.